TransMed7 is a brand that specializes in transformational forward-coring biopsy devices called Zero5. These innovative devices encompass a wide range of applications, including breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, and even bone marrow biopsy. By leveraging the principles of precision and control found in nature's most skillful surgeon, the hummingbird, TransMed7's Zero5 technology enables repeatable access to every part of the body for various procedures such as removal, delivery, revelation, and replacement.

The patented and FDA-cleared rotating beak design sets Zero5 apart from traditional side-cutting devices, offering five critical advantages: zero dead space, zero tissue displacement, no limitations on sample length, no restrictions on tissue density, and zero sample structure distortion. TransMed7 also applies Zero5 to handheld ultrasound-guided soft tissue biopsy (SpeedBird) and stereotactic/2D-3D tomosynthesis or ultrasound-guided soft tissue biopsy (Concorde), as well as true Fine Needle Core Biopsy (Cardinal) for lymph node, thyroid, liver, pancreas, and kidney samples. TransMed7 aims to meet the challenges of biopsy procedures with their revolutionary Zero5 technology, making them a leader in forward-coring biopsy devices